Skip to main content

It’s Time to Re-Evaluate Rinse™ – LISTERINE® at EuroPerio11 in Vienna

  1. Members Area
  2. News
  3. It’s Time to Re-Evaluate Rinse™ – LISTERINE® at EuroPerio11 in Vienna

It’s Time to Re-Evaluate Rinse™ – LISTERINE® at EuroPerio11 in Vienna

15 May 2025 (Last updated: 15 May 2025 10:07)

LISTERINE® is a proud gold sponsor of EuroPerio11, the premier global event in periodontology, oral health, and implantology, taking place from 14th–17th May 2025 in Vienna.

Maintaining good oral health is essential for overall well-being. Despite being largely preventable, periodontal diseases continue to rise globally. While mechanical plaque control is key, controlling plaque biofilm accumulation—even in hard-to-reach areas—is crucial. A wealth of evidence—including systematic reviews, meta-analyses, the European Federation of Periodontology’s (EFP) S3-level stage I-III clinical practice guideline, and a recent consensus report from global experts convened by SEPA*—supports the adjunctive use of antiseptic mouth rinses, with essential oils as one of the most effective antiseptic agents in reducing plaque and controlling gingival inflammation.

Backed by more than 75 years of research and over 50 clinical studies, LISTERINE® mouth rinse, powered by clinically proven essential oils, delivers evidence-based adjunctive benefits to mechanical biofilm control.

Join us at stand A10 for an interactive biofilm journey, experience our alcohol-free LISTERINE Total Care® Milder Taste at our mouth rinsing station, and speak with our team to discover why now is the time to Re-Evaluate Rinse™.

*Sponsored by LISTERINE®

Evidence-Based Insights: LISTERINE® Sponsored Session

LISTERINE® is also sponsoring a key session as part of the Principles for Oral Health initiative with the SEPA Foundation. Join this expert-led panel discussion at 12:30 on Friday 16th May in the Schubert Room:

Antiseptics: WHY, WHEN, and HOW – An Evidence-Based Approach

Moderated by Paula Matesanz, the session will feature insights from leading experts, including David Herrera, Simone Ruzario, Soha Dattani, Mariano Sanz, Ricardo Fischer, Henrik Dommisch, and Marjolaine Gosset.

This session will:

  • Define optimal conditions for the use of oral antiseptics by professionals and their patients, based on the recommendations of the EFP’s Stage I–III S3-level Clinical Practice Guideline.
  • Explore the economic impact of gum-related issues and the importance of effective at-home self-care.
  • Examine key indications, patient groups, and clinical benefits of the adjunctive use of antiseptics.

 

Lunch will be provided.

Find Out More:

Back to News